Peiling Xie
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Breast Cancer Treatment Studies 2
- Cancer Genomics and Diagnostics 1
- Oncology 4
- Co-authors
- Jianjun He (6 shared papers)Huimin Zhang (7 shared papers)Shibo Yu (6 shared papers)Na Hao (1 shared paper)Peijun Liu (1 shared paper)Gregg L. Semenza (1 shared paper)Yang Liu (1 shared paper)Xiaoxu Liu (2 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Frontiers in Immunology (2 papers)PLoS ONE (1 paper)Clinical Medicine (1 paper)Frontiers in Genetics (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Peiling Xie
21 papers receiving 305 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 62
- Biomaterials 38
- Oncology 66
- Pharmaceutical Science 12
- Pulmonary and Respiratory Medicine 56
Countries citing papers authored by Peiling Xie
This map shows the geographic impact of Peiling Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiling Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiling Xie more than expected).
Fields of papers citing papers by Peiling Xie
This network shows the impact of papers produced by Peiling Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiling Xie. The network helps show where Peiling Xie may publish in the future.
Co-authors
The 25 scholars most cited alongside Peiling Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 78 | |
| 2 | 2022 | 42 | |
| 3 | 2020 | 31 | |
| 4 | 2017 | 31 | |
| 5 | 2016 | 30 | |
| 6 | 2022 | 13 | |
| 7 | 2019 | 13 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 12 | |
| 10 | 2020 | 7 | |
| 11 | 2021 | 7 | |
| 12 | 2023 | 7 | |
| 13 | 2020 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2019 | 2 |
About Peiling Xie
Peiling Xie is a scholar working on Cancer Research, Oncology, Biomaterials, Cell Biology and Molecular Biology, having authored 21 papers that have together received 308 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (2 papers), Breast Cancer Treatment Studies (2 papers), Nanomaterials for catalytic reactions (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Phase Change Materials Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Intraocular Surgery and Lenses (1 paper). The work is most often cited by research in Cancer Research (62 citations), Biomaterials (38 citations), Oncology (66 citations), Pharmaceutical Science (12 citations) and Pulmonary and Respiratory Medicine (56 citations). Peiling Xie has collaborated with scholars based in China and United States. Frequent co-authors include Jianjun He, Huimin Zhang, Shibo Yu, Na Hao, Peijun Liu, Gregg L. Semenza, Yang Liu, Xiaoxu Liu, Miao Zhang and Miao Zhang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, PLoS ONE, Clinical Medicine and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.